000 01593 a2200457 4500
005 20250516201525.0
264 0 _c20140604
008 201406s 0 0 eng d
022 _a1528-0020
024 7 _a10.1182/blood-2013-10-532374
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHavelange, Violaine
245 0 0 _aImplications of the miR-10 family in chemotherapy response of NPM1-mutated AML.
_h[electronic resource]
260 _bBlood
_cApr 2014
300 _a2412-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aMembrane Glycoproteins
_xgenetics
650 0 4 _aMutation
650 0 4 _aNuclear Proteins
_xgenetics
650 0 4 _aNucleophosmin
650 0 4 _aOligonucleotide Array Sequence Analysis
650 0 4 _aReceptors, Immunologic
_xgenetics
700 1 _aRanganathan, Parvathi
700 1 _aGeyer, Susan
700 1 _aNicolet, Deedra
700 1 _aHuang, Xiaomeng
700 1 _aYu, Xueyan
700 1 _aVolinia, Stefano
700 1 _aKornblau, Steven M
700 1 _aAndreeff, Michael
700 1 _aCroce, Carlo M
700 1 _aMarcucci, Guido
700 1 _aBloomfield, Clara D
700 1 _aGarzon, Ramiro
773 0 _tBlood
_gvol. 123
_gno. 15
_gp. 2412-5
856 4 0 _uhttps://doi.org/10.1182/blood-2013-10-532374
_zAvailable from publisher's website
999 _c23610715
_d23610715